PCSK9 and Other Novel Hypercholesterolemia Drugs Market 2014 2024
LONDON Sept. 15 2014 PRNewswire INTRODUCTIONWorldwide statistics indicate that there is a high cholesterol burden despite the presence of many cholesterollowering drugs in the market. Out of all the...
View ArticleGeneric Statins Boost Patient Adherence Outcomes
MedPage Today Going offbrand for statin medication modestly improved adherence and cardiovascular outcomes an observational study showed.
View ArticleCVS Health Research Institute Study is First to Show Improved Medication...
WOONSOCKET R.I. Sept. 15 2014 PRNewswire A new study by researchers at CVS Health NYSE CVS and Brigham and Women's Hospital published today in the Annals of Internal Medicine is the first to...
View ArticleAmarin Reaffirms Its Mission to Improve Patient Care With Commitment to...
BEDMINSTER NJ and DUBLIN IRELANDMarketwired September 16 2014 Amarin Corporation plc NASDAQ AMRN a biopharmaceutical company focused on the commercialization and development of therapeutics to improve...
View ArticleSynthetic Biologics' StatinClass Candidate for ConstipationPredominant...
ROCKVILLE Md. Sept. 16 2014 PRNewswire &160;Synthetic Biologics Inc. NYSE MKT SYN a biotechnology company developing novel antiinfective biologic and drug programs targeting specific pathogens that...
View ArticleEvaluation and Treatment of Older Patients With Hypercholesterolemia A...
ImportanceHypercholesterolemia is common among people older than 80 years. Substantial functional heterogeneity exists among older patients and decision making for statin use differs in older patients...
View ArticleResearchers use iPS cells to show statin effects on diseased bone
Skeletal dysplasia is a group of rare diseases that afflict skeletal growth through abnormalities in bone and cartilage. Its onset hits at the fetal stage and is caused by genetic mutations. A mutation...
View ArticleStatin treatment among over80 age group must always be assessed individually
The need for cholesterol treatment among people over 80 must always be assessed individually by taking into account the patients overall situation and health experts recommend. The number of...
View ArticleReassuring findings on microvascular risk in diabetic statin users
Statin treatment prior to diabetes onset does not appear to increase the risk of microvascular disease and may even be protective against some forms findings from a registry study suggest.
View ArticleStatin treatment rescues FGFR3 skeletal dysplasia phenotypes
This study reprograms fibroblasts from thanatophoric dysplasia type I TD1 and achondroplasia ACH patients into induced pluripotent stem cells iPSCs finding that chondrogenic differentiation results in...
View ArticleJapan Scientists Combine Statins iPS Cells For Bone Disease
Japan researchers suggest combining anticholesterol statin drugs with a stem cell treatment could aid patients with skeletal dysplasia a genetic bone disease.
View ArticleGATM locus does not replicate in rhabdomyolysis study
Arising from L. M. Mangravite et al. Nature502377380 2013; doi10.1038nature12508All HMGCoA reductase inhibitors statins can cause muscle injury ranging from asymptomatic elevations in creatine kinase...
View ArticleGATM gene variants and statin myopathy risk
Arising from L. M. Mangravite et al. Nature502377380 2013; doi10.1038nature12508Mangravite et al. identified six expression quantitative loci eQTLs that interacted with simvastatin exposure by using...
View ArticleMangravite et al. reply
Replying to D. F. Carr et al.Nature513 httpdx.doi.org10.1038nature13628 2014; J. S. Floyd et al.Nature513 httpdx.doi.org10.1038nature13629 2014Our study tested for associations of singlenucleotide...
View ArticleInduced pluripotent stem cells used to show statin effects on diseased bone
Scientists have generated induced pluripotent stem cells iPSCs from fibroblasts of patients with thanatophoric dysplasia or achondroplasia two types of skeletal dysplasia and recapitulated the symptoms...
View ArticlePharmaPoint Acute Coronary Syndrome US Drug Forecast and Market Analysis to 2023
Recently added to the BioPortfolio report storePharmaPoint Acute Coronary Syndrome US Drug Forecast and Market Analysis to 2023 is a new report fromGlobalData published on 20140730.This 233page...
View ArticlePharmaPoint Acute Coronary Syndrome Japan Drug Forecast and Market Analysis...
Recently added to the BioPortfolio report storePharmaPoint Acute Coronary Syndrome Japan Drug Forecast and Market Analysis to 2023 is a new report fromGlobalData published on 20140730.This 218page...
View ArticlePharmaPoint Acute Coronary Syndrome 5EU Drug Forecast and Market Analysis to...
Recently added to the BioPortfolio report storePharmaPoint Acute Coronary Syndrome 5EU Drug Forecast and Market Analysis to 2023 is a new report fromGlobalData published on 20140730.This 277page...
View ArticleXarelto Acute Coronary Syndrome Forecast and Market Analysis to 2023
Recently added to the BioPortfolio report storeXarelto Acute Coronary Syndrome Forecast and Market Analysis to 2023 is a new report fromGlobalData published on 20140730.This 91page reportis available...
View ArticleCrestor Acute Coronary Syndrome Forecast and Market Analysis to 2023
Recently added to the BioPortfolio report storeCrestor Acute Coronary Syndrome Forecast and Market Analysis to 2023 is a new report fromGlobalData published on 20140730.This 60page reportis available...
View Article